Evaluation of enophthalmos due to ophthalmic solution for glaucoma

Evaluation of enophthalmos due to ophthalmic solution for glaucoma - Enophthalmos due to ophthalmic solution for glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018596

Enrollment

Registered

2015-08-07

Start date

2015-08-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients of Shiga University of Medical Science Hospital that start the treatment with bimatoprost ophthalmic solution for glaucoma

Exclusion criteria

Exclusion criteria: Patients who have the history of the treatment with prostaglandin ophthalmic solution Patients who can not undergo MRI examination

Design outcomes

Primary

Measure	Time frame
Variation on a value of proptosis	—

Secondary

Measure	Time frame
Variation on a volume of orbital fatty tissue	—

Countries

Japan

Contacts

Public ContactTomoaki Higashiyama

Shiga University of Medical Science Department of Ophthalmology

higashi@belle.shiga-med.ac.jp0775482276

Outcome results